SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Anonymous. Cancer care during the last phase of life. J Clin Oncol. 1998; 16: 19861996.
  • 2
    Decoster G, Stein G, Holdener EE. Responses and toxic deaths in phase I clinical trials. Ann Oncol. 1990; 2: 175181.
  • 3
    Von Hoff DD, Turner J. Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs. 1991; 9: 115122.
  • 4
    Daugherty C, Ratain MJ, Growchowski E, et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995; 13: 10621072.
  • 5
    Schutta KM, Burnett CB. Factors that influence a patient's decision to participate in a phase I cancer clinical trial. Oncol Nurs Forum. 2000; 27: 14351438.
  • 6
    Annas GJ. Informed consent, cancer, and truth in prognosis. N Engl J Med. 1993; 330: 223225.
  • 7
    Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep. 2000; 30: 3443.
  • 8
    Markman M. The ethical dilemma of phase I clinical trials. CA. 1986; 36: 367369.
  • 9
    Sachs GA. Opportunities for promoting palliative medicine in cancer research. Cancer Invest. 1998; 16: 503.
  • 10
    Office of the Inspector General. Medicare hospice beneficiaries: services and eligibility (Report OEI-04-93-00270). Washington, DC: Government Printing Office, 1993.
  • 11
    National Hospice Organization: Standards and Accreditation Committee 1995-6. A pathway for patients and families facing terminal illness. Arlington, VA: National Hospice Organization, 1997.
  • 12
    42 Code of Federal Regulations, Part 418 Medicare Hospice Regulations. 1996.
  • 13
    Itoh K, Sasaki Y, Fujii H, Wakita H, Igarashi T, Abe K. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer. 1997; 76: 107113.
  • 14
    Rodenhuis S, Van den Huevel W, Annyas A, Koops H, Sleijfer D, Mulder N. Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol. 1984; 20: 457462.
  • 15
    http://cancertrials.nci.nih.gov. Accessed January 23, 2001.
  • 16
    National Hospice Organization Fact Sheet. 2000:http://www.nho.org/facts.htm.
  • 17
    Casarett D, Abrahm J. Comparison of patients referred to hospice vs. a bridge program: patient characteristics, needs for care, and survival. J Clin Oncol. 2001; 19: 20572063.